Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Dronedarone on Atrial Fibrosis Progression and Atrial Fibrillation Recurrence Post Ablation: The EDORA Trial

NCT04704050 is registered in ClinicalTrials.gov with Tulane University School of Medicine as lead sponsor.

NCT NCT04704050
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04704050 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Dronedarone on Atrial Fibrosis Progression and Atrial Fibrillation Recurrence Post Ablation: The EDORA Trial
Lead sponsor
Tulane University School of Medicine
Phase
Phase 4
Overall status
Terminated
Start date
May 15, 2021
Completion date
December 20, 2022
Enrollment
22 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation, atrial fibrillation recurrent